腰骶神经根丛神经病:发病率及其与糖尿病的关联
该研究基于美国明尼苏达州奥姆斯特德县居民2000至2015年的病历数据,采用临床和电生理标准识别腰骶神经根丛神经病(LRPN),并依据美国糖尿病协会标准判定糖尿病。共确认59例LRPN患者,总发病率为4.16/10万人年(95%CI 3.13-5.18),糖尿病是LRPN的主要危险因素,支持将LRPN分为糖尿病型和非糖尿病型。
要点
- LRPN总发病率为4.16/10万人年,高于同人群其他免疫介导性神经病。
- 糖尿病患者LRPN风险显著增高,比值比为7.91。
- 糖尿病前期与LRPN无显著关联。
核心结论
- LRPN在奥姆斯特德县的发病率为4.16/10万人年,使其成为一种常见的炎性神经病,且高于同人群评估的其他免疫介导性神经病。
- 糖尿病是LRPN的主要危险因素,支持继续将LRPN分为糖尿病型和非糖尿病型。
研究设计与样本
- 基于罗切斯特流行病学项目,回顾性识别2000至2015年奥姆斯特德县居民中符合临床和电生理标准的LRPN患者。
- 共审查1892份病历,确认59例LRPN患者(33男,26女),中位年龄70岁(范围24-88岁)。
- 糖尿病依据美国糖尿病协会标准判定,并设对照组比较。
主要发现
- LRPN患者中糖尿病比对照组更常见(39/59 vs 35/177,p < 0.001),糖尿病前期无显著差异(10/20 vs 55/142,p = 0.336)。
- 3例糖尿病患者LRPN复发,研究期间共62次LRPN发作。
- LRPN总发病率为4.16/10万人年(95%CI 3.13-5.18)。
- 糖尿病组和非糖尿病组LRPN发病率分别为2.79/10万人年(95%CI 1.94-3.64)和1.27/10万人年(95%CI 0.71-1.83)。
- 糖尿病和糖尿病前期患者LRPN的比值比分别为7.91(95%CI 4.11-15.21)和1.006(95%CI 1.004-1.012)。
关键数值与推荐
- LRPN定义基于临床和电生理标准。
- 糖尿病判定采用美国糖尿病协会标准。
- LRPN总发病率4.16/10万人年(95%CI 3.13-5.18)。
临床怎么用
- 临床遇到腰骶神经根丛神经病患者时应评估糖尿病,因其为重要危险因素。
- LRPN发病率较高,应纳入炎性神经病鉴别诊断。
- 糖尿病前期与LRPN关联不显著,无需作为常规筛查重点。
局限性
- 本研究为回顾性研究,基于病历数据,可能存在信息偏倚。
- 研究人群为单一县居民,结果外推需谨慎。
- 未报告LRPN的具体治疗和预后数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine the previously unknown incidence of lumbosacral radiculoplexus neuropathy (LRPN) and its association with diabetes mellitus (DM). METHODS: LRPN defined by clinical and electrophysiologic criteria was identified among Olmsted County, Minnesota, residents during a 16-year period (2000-2015) using the unique facilities of the Rochester Epidemiology Project. DM was ascertained using American Diabetes Association criteria. RESULTS: Of 1,892 medical records reviewed, 59 patients (33 men, 26 women) were identified as having LRPN. The median age was 70 years (range 24-88 years) and the median time of onset of symptoms to diagnosis was 2 months (range 1-72 months). DM was more frequent in patients with LRPN than in controls (39/59 vs 35/177, p < 0.001) but not in those with pre-DM (10/20 vs 55/142, p = 0.336). LRPN recurred in 3 patients with DM resulting in 62 LRPN episodes during the study period. The overall incidence of LRPN was 4.16/100,000/y (95% confidence interval [CI] 3.13-5.18). The incidences of LRPN among DM and non-DM groups were 2.79/100,000/y (95% CI 1.94-3.64) and 1.27/100,000/y (95% CI 0.71-1.83), respectively. The odds of LRPN among patients with DM and pre-DM was 7.91 (95% CI 4.11-15.21) and 1.006 (95% CI 1.004-1.012), respectively. CONCLUSIONS: LRPN incidence in Olmsted County of 4.16/100,000/y makes LRPN a common inflammatory neuropathy and is higher than that of other immune-mediated neuropathies (acute or chronic inflammatory demyelinating polyradiculoneuropathy, brachial plexus neuropathy) assessed within the same population. DM is a major risk factor for LRPN and thus justifies the continued classification of LRPN into diabetic and nondiabetic forms.
引用
- Ng PS, Dyck PJ, Laughlin RS, et al. Lumbosacral radiculoplexus neuropathy: Incidence and the association with diabetes mellitus. Neurology. 2019. PMID: 30760636. doi:10.1212/WNL.0000000000007020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。